The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Wednesday, April 23, 2014 3:00:44 AM

Colonoscopy Adenoma Detection Rate Is Inversely Proportional to Risk of In...4/18/2014 12:13:14 PM - Matthew Stenger

FDA Approves Ofatumumab for Previously Untreated Chronic Lymphocytic Leuke...4/17/2014 3:52:03 PM - The ASCO Post

Living and Working with CancerAugust 15, 2013, Volume 4, Issue 13 - Jo Cavallo

Total Parotidectomy May Benefit Patients With Cutaneous Squamous Cell Carc...4/17/2014 3:48:05 PM - Matthew Stenger

Panitumumab Not Inferior to Cetuximab in Overall Survival in Chemotherapy-...4/17/2014 2:49:21 PM - Matthew Stenger

Omega-3November 15, 2013, Volume 4, Issue 18 - Jyothirmai Gubili, MS Editor, Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center

Volasertib Granted Orphan Drug Designation for Acute Myeloid Leukemia4/17/2014 12:30:42 PM - The ASCO Post

Novel Prognostic Indices Validated for Cytogenetically Normal Acute Myeloi...4/17/2014 12:26:50 PM - Matthew Stenger

High Rate of Durable Remissions with Ibrutinib in Patients with Relapsed C...August 15, 2013, Volume 4, Issue 13 - Matthew Stenger

Novel Blood-Based Biomarkers May Predict Breast Cancer Recurrence and Trea...4/16/2014 4:02:10 PM - Jo Cavallo

Featured Columnists

The Outlook on Cancer Research in This Era of Leaner Federal Funding Douglas R. Lowy, MD  

I Refuse to Capitulate to Cancer Paul Kalanithi, MD  

The Future of Biomedical Research Francis S. Collins, MD, PhD  

More Featured Columnists

Expert Opinions

Detecting Accelerated Aging in Adult Survivors of Childhood Cancer Kirsten K. Ness, PhD  

Determining Why Younger Women With Breast Cancer Are Less Likely to Survive Than Their Older Counterparts Theresa Keegan, PhD, MS  

Unraveling the Molecular Complexity of Multiple Myeloma Sagar Lonial, MD  

More Expert Opinions

Meeting News

State-of-the-Art Update on Renal Cell Carcinoma Cetuximab Fails to Improve Survival in Nonoperable Esophageal Cancer Better Options Emerging for Salvage Therapy in Hodgkin Lymphoma ‘Double-Hit’ Lymphomas a Challenge for the Oncologist More Meeting News

Journal Spotlight

SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Surgery in ... Bladder Cancer Patient With Rare Genetic Mutations Shows Exceptional Respo... No Mortality Benefit of Mammography Screening in 25-Year Follow-up of Cana... FACS Trial: Intensive Follow-up Increases Surgical Treatment of Recurrence... More Journal Spotlights

Health-Care Policy

ASCO Releases Its First-Ever Report on the State of Cancer Care in America Cancer Research Funding Still Tight—and Getting Tighter Informed Consent: Not Just About Blood Tests and Procedures Anymore Decision Time for Lung Cancer Screening in High‑Risk Populations More Health-care Policy

Drugs & Regimens

‘Double-Hit’ Lymphomas a Challenge for the Oncologist Targeting Cancer Stem Cells in Breast Cancer: A Potential Clinical Strategy Cetuximab Fails to Improve Survival in Nonoperable Esophageal Cancer FACS Trial: Intensive Follow-up Increases Surgical Treatment of Recurrence With Curative Intent in Colorectal Cancer More Drugs & Regimens

Oncology Worldwide

National Program to Screen Ashkenazi Women in Israel for BRCA Mutations Is Being Explored UN Agency Issues World Cancer Report 2014 IPOS/AORTIC Conference Aims to Bring Comprehensive Care to Patients in Africa Reports From the IPOS/AORTIC Travel Scholars More Oncology Worldwide

Patient's Corner

Cancer Has Allowed Me to Put My Goals First Nothing Prepared Me for Cancer Cancer Is in My Soul Cancer Has Given Me a Greater Appreciation for Life More Patient's Corner
More on Twitter